Chemotherapy drug for high-risk liver hepatocellular carcinoma (HCC) patients
Shown to have greater sensitivity in treating high-risk HCC patients
Classification by use
Chemotherapy drugs
A trustworthy factory and manufacturer
Anoikis- and m6A-related lncRNA analysis to identify prognostic indicators in liver hepatocellular carcinoma, Electronic Journal of Biotechnology, Volume 79, January 2026, 100701